🇪🇺 Test Glucophage® XR in European Union

EMA authorised Test Glucophage® XR on 11 November 2019

Marketing authorisation

EMA — authorised 11 November 2019

  • Application: EMEA/H/C/004910
  • Marketing authorisation holder: AstraZeneca AB
  • Local brand name: Qtrilmet
  • Indication: Qtrilmet is indicated in adults aged 18 years and older with type 2 diabetes mellitus: to improve glycaemic control when metformin with or without sulphonylurea (SU) and either saxagliptin or dapagliflozin does not provide adequate glycaemic control. when already being treated with metformin and saxagliptin and dapagliflozin.
  • Status: withdrawn

Read official source →

Frequently asked questions

Is Test Glucophage® XR approved in European Union?

Yes. EMA authorised it on 11 November 2019.

Who is the marketing authorisation holder for Test Glucophage® XR in European Union?

AstraZeneca AB holds the EU marketing authorisation.